Fig. 2
From: RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway
RPL15 unregulated in HCC predicted poor prognosis of HCC patients. A The expression of RPL15 was unregulated in T (tumor tissue) compared to N (negative para-carcinoma tissue) in TCGA HCC dataset. B, C Kaplan–Meier analysis indicated that HCC patients with high RPL15 expression displayed a significantly shorter overall survival (OS), but not obvious disease-free survival (DFS), the dotted lines mean 95% Confidengce Interval. *P < 0.05, compared to the control group